NewGenIvf Statistics
Share Statistics
NewGenIvf has 730.28K
shares outstanding. The number of shares has increased by 0.07%
in one year.
| Shares Outstanding | 730.28K |
| Shares Change (YoY) | 0.07% |
| Shares Change (QoQ) | 0.07% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,850 |
| FTD / Avg. Volume | 0.43% |
Short Selling Information
The latest short interest is 128.5K, so 17.12% of the outstanding
shares have been sold short.
| Short Interest | 128.5K |
| Short % of Shares Out | 17.12% |
| Short % of Float | 17.6% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -8.79 and the forward
PE ratio is null.
NewGenIvf's PEG ratio is
0.09.
| PE Ratio | -8.79 |
| Forward PE | n/a |
| PS Ratio | 0.85 |
| Forward PS | n/a |
| PB Ratio | -4.4 |
| P/FCF Ratio | -0.55 |
| PEG Ratio | 0.09 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for NewGenIvf.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17,
with a Debt / Equity ratio of -2.89.
| Current Ratio | 1.17 |
| Quick Ratio | 1.14 |
| Debt / Equity | -2.89 |
| Debt / EBITDA | 125.67 |
| Debt / FCF | -0.36 |
| Interest Coverage | -1.49 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $71,491.78 |
| Profits Per Employee | $-6,903.2 |
| Employee Count | 76 |
| Asset Turnover | 1.52 |
| Inventory Turnover | 44.63 |
Taxes
| Income Tax | -486.71K |
| Effective Tax Rate | 50.66% |
Stock Price Statistics
The stock price has increased by -85.11% in the
last 52 weeks. The beta is 0.25, so NewGenIvf's
price volatility has been higher than the market average.
| Beta | 0.25 |
| 52-Week Price Change | -85.11% |
| 50-Day Moving Average | 4.39 |
| 200-Day Moving Average | 5.26 |
| Relative Strength Index (RSI) | 31.82 |
| Average Volume (20 Days) | 433,762 |
Income Statement
In the last 12 months, NewGenIvf had revenue of 5.43M
and earned -524.64K
in profits. Earnings per share was 0.
| Revenue | 5.43M |
| Gross Profit | 1.83M |
| Operating Income | -1.16M |
| Net Income | -524.64K |
| EBITDA | 24.11K |
| EBIT | -182.15K |
| Earnings Per Share (EPS) | 0 |
Full Income StatementBalance Sheet
The company has 457.74K in cash and 3.03M in
debt, giving a net cash position of -2.57M.
| Cash & Cash Equivalents | 457.74K |
| Total Debt | 3.03M |
| Net Cash | -2.57M |
| Retained Earnings | -985.99K |
| Total Assets | 3.78M |
| Working Capital | 452.39K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -8.26M
and capital expenditures -53.04K, giving a free cash flow of -8.32M.
| Operating Cash Flow | -8.26M |
| Capital Expenditures | -53.04K |
| Free Cash Flow | -8.32M |
| FCF Per Share | -7.31 |
Full Cash Flow StatementMargins
Gross margin is 33.62%, with operating and profit margins of -21.36% and -9.66%.
| Gross Margin | 33.62% |
| Operating Margin | -21.36% |
| Pretax Margin | -17.68% |
| Profit Margin | -9.66% |
| EBITDA Margin | 0.44% |
| EBIT Margin | -21.36% |
| FCF Margin | -153.07% |
